Stock VENUSREM VENUS REMEDIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Venus Remedies Limited NSE India S.E.

Equities

VENUSREM

INE411B01019

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:43:49 2024-04-26 am EDT 		5-day change 1st Jan Change
328.4 INR +0.06% Intraday chart for Venus Remedies Limited -0.09% -19.16%
Mar. 19 Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs MT
Mar. 08 Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products MT

Business Summary

Venus Remedies Ltd is a research-based pharmaceutical company. The Company is a global injectable manufacturer, possessing a wide product basket catering to therapeutic segments of anti-infective specially in antimicrobial resistance (AMR), oncology, skin and wound care and pain management. The Company operates in the Pharmaceutical Formulation segment. It manufactures products catering to the critical care and super specialty segments. The Company's product portfolio includes formulations such as injectables, tablets, and topical preparations. The Company offers solutions in the domains of antimicrobial resistance (AMR), oncology, skin & wound care, neurology, anticoagulants, pain management, herbal portfolio and disinfectants. Its focus therapy areas include medicine, surgery, neuro and orthopedics. The Company’s brands include Potentox, Vancoplus Combi, Tobracef, Supime, Zydotum, Neurotol, Trois, Septiloc, Mucomelt, Ventaful and Nervolize. It has three manufacturing facilities.

Number of employees: 998

Sales per Business

INR in Million2022Weight2023Weight Delta
Pharmaceutical Formulation
99.4 %
5,980 99.9 % 5,524 99.4 % -7.62%
Other
0.4 %
- - 21 0.4 % -
Research Activities
0.2 %
7 0.1 % 9 0.2 % +40.90%

Sales per region

INR in Million2022Weight2023Weight Delta
India
100.0 %
5,986 100.0 % 5,555 100.0 % -7.21%

Managers

Managers TitleAgeSince
Ashutosh Jain CEO
 Chief Executive Officer 46 07-04-30
Pawan Chaudhary CHM
 Chairman 59 89-09-14
Jitendra Singh ADM
 Chief Administrative Officer - 98-12-31
Akshansh Chaudhary CTO
 Chief Tech/Sci/R&D Officer - 19-12-31
Neha Kodan CMP
 Compliance Officer - 11-04-10
Manu Chaudhary BRD
 Director/Board Member 55 92-04-25
Peeyush Jain BRD
 Director/Board Member 52 -
Manav Soni PRN
 Corporate Officer/Principal - -
Rajiv Sharma SAM
 Sales & Marketing - 97-12-31
Kamal Joshi PRN
 Corporate Officer/Principal - 05-12-31

Members of the board

Members of the board TitleAgeSince
Gilbert Wenzel BRD
 Director/Board Member 67 -
Peeyush Jain BRD
 Director/Board Member 52 -
Ashutosh Jain CEO
 Chief Executive Officer 46 07-04-30
Pawan Chaudhary CHM
 Chairman 59 89-09-14
Manu Chaudhary BRD
 Director/Board Member 55 92-04-25
Suresh Kumar Chadha BRD
 Director/Board Member 67 -
Navdeep Sud BRD
 Director/Board Member 65 20-06-19
Akshansh Chaudhary CTO
 Chief Tech/Sci/R&D Officer - 19-12-31
Savita Gupta BRD
 Director/Board Member 52 21-12-29
NPS Monga BRD
 Director/Board Member - 23-05-28

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,366,988 7,056,795 ( 52.79 %) 0 52.79 %

Shareholders

NameEquities%Valuation
Sunev Pharma Solutions Ltd.
17.21 %
2,300,000 17.21 % 9 M ₹
Pawan Chaudhary
12.82 %
1,713,946 12.82 % 7 M ₹
Manu Chaudhary
11.73 %
1,568,000 11.73 % 6 M ₹
K B Shekar
1.919 %
256,530 1.919 % 1 M ₹
Government of India
1.004 %
134,241 1.004 % 525 359 ₹
Franklin Templeton Asset Management (India) Pvt Ltd.
0.0898 %
12,000 0.0898 % 46 963 ₹

Company contact information

Venus Remedies Ltd.

Plot 51-52, Industrial Area Phase-1

134113, Panchkula

+91 17 2393 3090

http://www.venusremedies.com
address Venus Remedies Limited(VENUSREM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 526953 Stock
  4. VENUSREM Stock
  5. Company Venus Remedies Limited